WO2017119130A1 - Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method - Google Patents
Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method Download PDFInfo
- Publication number
- WO2017119130A1 WO2017119130A1 PCT/JP2016/050560 JP2016050560W WO2017119130A1 WO 2017119130 A1 WO2017119130 A1 WO 2017119130A1 JP 2016050560 W JP2016050560 W JP 2016050560W WO 2017119130 A1 WO2017119130 A1 WO 2017119130A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- light intensity
- living body
- blood
- scattering coefficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
Definitions
- the present invention relates to a biological lipid measuring instrument that can measure lipid in blood in a living body non-invasively, and a biological lipid measuring method that can measure lipid in blood in a living body non-invasively About.
- Patent Document 1 light in the near-infrared region or in the infrared region is output by an acousto-optic variable vibration filter and irradiated on a living body, and light transmitted through or reflected by a non-measurement object is received.
- An invention relating to an apparatus for calculating the concentration of a non-measurement object by analyzing and calculating the obtained absorption spectrum is disclosed.
- Patent Document 2 discloses that the living body is irradiated with light, the light intensity emitted from the living body is detected, the scattering coefficient of the detection light is calculated, and the lipid concentration in the living body is determined by using the scattering coefficient.
- An invention relating to an apparatus for calculating is disclosed.
- Patent Document 2 opens the way to measure lipids in a living body with high accuracy using optical scattering, makes it possible to easily measure the lipid concentration in a living body, and tests for metabolic abnormalities, etc. Application to is expected.
- the technique disclosed in Patent Document 2 cannot distinguish between light that has actually passed through blood and light that has not passed through among detection light emitted from a living body. For this reason, there has been a problem that the irradiation unit and the detection unit need to be aligned so that light from the irradiation unit is reliably transmitted through the blood. Furthermore, even when trying to align, depending on the color and constitution of the skin, the position of the blood vessel cannot always be confirmed through the skin, so that there is a difficulty in the alignment itself.
- the present inventors have found that light transmitted through the blood has a large absorption in addition to scattering, and when measured at the same position from the light source, the light transmitted through the blood is It was found that the intensity was remarkably attenuated compared to light that did not pass through the blood. Then, when calculating the scattering coefficient, it is possible to solve the above problem by determining whether or not the detection light is transmitted through the blood and calculating the scattering coefficient of the light determined to be transmitted through the blood. The present invention has been completed.
- the gist of the present invention is as follows.
- a noninvasive living body lipid measuring instrument for measuring lipids in blood in a living body An irradiation unit that emits light at a predetermined light intensity from outside the living body toward the living body;
- a light intensity detection unit that detects light intensity emitted from the living body through scattering of the irradiation light from the irradiation unit;
- a scattering coefficient calculation unit that calculates a scattering coefficient of light in the living body based on the light intensity detected by the light intensity detection unit;
- a lipid concentration calculator that calculates a lipid concentration based on the calculated scattering coefficient,
- the scattering coefficient calculation unit determines whether or not the light intensity detected by the light intensity detection unit is transmitted through the blood in the living body, and is determined to have transmitted through the blood in the living body.
- the scattering coefficient calculation unit determines that the light having a light intensity equal to or lower than a preset threshold is the light intensity transmitted through the blood in the living body with respect to the plurality of detected light intensities.
- the scattering coefficient calculation unit compares a plurality of detected light intensities, and the light intensity normalized by the distance between the irradiation unit and the detection unit is the light intensity transmitted through the blood in the living body.
- the noninvasive living body lipid measuring device according to (1), which is determined to be present.
- the noninvasive biological lipid measuring instrument according to any one of (1) to (3), wherein a plurality of the irradiation units and / or the light intensity detection units are arranged. (5) A plurality of the light intensity detectors are arranged, and a filter that cuts the amount of light so that the light intensities detected by the plurality of light intensity detectors are substantially the same (1) to (1) 4) The noninvasive biological lipid measuring instrument according to any one of the above. (6) The non-invasive device according to any one of (1) to (5), wherein the irradiation unit can modulate the irradiation light, and the scattering coefficient calculation unit can calculate a scattering coefficient in accordance with the modulation of the irradiation light. Type biological lipid measuring instrument.
- a method for measuring lipids in blood in a living body An irradiation step of irradiating light at a predetermined light intensity from outside the living body toward the living body; A light intensity detection step of detecting light intensity emitted from the living body through scattering in the living body of the irradiation light in the irradiation step; A scattering coefficient calculating step for calculating a light scattering coefficient in the living body based on the light intensity detected by the light intensity detecting step; and a lipid concentration calculating step for calculating a lipid concentration based on the calculated scattering coefficient.
- the scattering coefficient calculating step includes a step of determining whether or not the light intensity detected by the light intensity detecting step is transmitted through the blood in the living body, and the blood in the living body is determined by the step. Calculating the scattering coefficient of the light determined to have passed through, A method for measuring non-invasive biological lipids.
- the present invention in a non-invasive biological lipid measuring instrument, it is possible to determine whether or not the detection light is transmitted through the blood without requiring precise alignment. Is possible.
- the number of light intensities that can be detected increases. Therefore, when linear conversion is used in the calculation of the scattering coefficient. Can significantly improve its accuracy.
- the scattering coefficient can be calculated using, for example, curve fitting without using linear transformation. Therefore, more complicated analysis can be performed.
- the upper surface schematic diagram (a) and the upper surface schematic diagram (b) which show the positional relationship of the irradiation part and light intensity detection part of the blood vessel of a biological body, and a noninvasive biological lipid measuring device. It is the upper surface schematic diagram (a), upper surface schematic diagram (b), and upper surface schematic diagram which show the positional relationship of the irradiation part and light intensity detection part of the blood vessel of a biological body, and a noninvasive biological lipid measuring device. It is an upper surface schematic diagram which shows the positional relationship of the irradiation part and light intensity
- FIG. 1 It is the schematic diagram (a) which shows one Embodiment of the blood vessel of a biological body, and a noninvasive biological lipid measuring device, and a schematic diagram (b). It is the front schematic diagram (a) of the form which applied the noninvasive biological lipid measuring device of this invention to the large sized device, and the front schematic diagram of the form which used the noninvasive biological lipid measuring device of this invention as the non-contact type device. .
- the non-invasive living body lipid measuring instrument 1 includes an irradiation unit 2 that irradiates light from outside the living body toward the living body, and the intensity of light emitted from the living body after the irradiation light from the irradiation unit is scattered in the living body.
- the calculation unit 4 includes a lipid concentration calculation unit 42 that calculates the lipid concentration in the living body based on the light scattering coefficient ⁇ S ′.
- the irradiating unit 2 irradiates a predetermined irradiation position with light from outside the living body toward the living body, and has a light source for irradiating light.
- the light source is adjusted such that its wavelength range is outside the wavelength range in which light is largely absorbed by substances such as plasma water and hemoglobin.
- blood means not only veins and arteries but also blood vessels including capillaries, but is preferably relatively thick blood vessels other than capillaries such as veins and arteries.
- the wavelength range in which light is absorbed by substances in plasma mainly indicates a range in which light absorption by water or hemoglobin in plasma is strong. That is, the wavelength range used as a light source is preferably 1400 nm or less in consideration of the wavelength range in which light is absorbed by water in plasma, and further, 580 nm in consideration of the wavelength range in which light is absorbed by hemoglobin.
- the thickness is more preferably 1400 nm or less.
- the irradiation unit 2 of the present embodiment irradiates light such as continuous irradiation of light or pulsed irradiation of light according to a calculation method of the scattering coefficient ⁇ S ′ by a scattering coefficient calculation unit 41 described later.
- the time length can be arbitrarily adjusted, and the intensity of light to be irradiated or the phase of light can be arbitrarily modulated.
- the irradiation unit 2 is modulated.
- the light intensity detection unit 3 can distinguish and detect light from the outside and light from the irradiation unit 2.
- the scattering coefficient calculation unit 41 needs to be able to calculate the scattering coefficient according to the modulation of the irradiation light.
- FIG. 1 only one irradiation unit 2 is shown, but a plurality of irradiation units 2 may exist. Since there are multiple irradiation units, it is easy to obtain multiple data with varying light intensity of the light source and the distance between the light irradiation unit and the light intensity detection unit, and linear conversion is performed in the calculation of the scattering coefficient. When used, the accuracy can be remarkably improved. On the other hand, the scattering coefficient can be calculated using, for example, curve fitting without using linear transformation.
- the light intensity detection unit 3 receives light and detects the light intensity, and the light emitted from the living body to the outside of the living body after the irradiation light from the irradiation unit is scattered in the living body is detected by the photodetector.
- the light intensity can be detected and the light intensity can be detected.
- strength detection part 3 you may install in each different distance centering
- the light intensity detectors can be arranged in order on the same surface and in a straight line at a predetermined interval from the irradiation position, but is not limited thereto.
- a predetermined distance is provided between an irradiation position for irradiating the living body with light and a detection position for detecting the light intensity emitted from the living body.
- the irradiated light is reflected by the scatterer in the living body surface and the vicinity of the surface, and the influence of the light emitted directly from the living body can be suppressed.
- the light intensity of the backscattered light emitted from the living body through scattering by blood lipid can be measured.
- the detection light emitted from the living body does not distinguish between light that has actually passed through blood and light that has not passed through, it may not be possible to obtain an accurate biological lipid concentration.
- the arrangement in the case of providing a plurality of detection positions is not limited to a straight line as long as they are arranged at different distances around the irradiation position, but are not limited to a circular shape, a wavy shape, a zigzag shape, a fan shape, Can be selected as appropriate, such as a two-dimensional array.
- interval of detection positions are not limited to a fixed space
- the scattering coefficient calculation unit 41 calculates a light scattering coefficient ⁇ S ′ in the living body based on the light intensity detected by the light intensity detection unit 3. Then, in the calculation unit 4, the lipid concentration calculation unit 42 calculates the lipid concentration using the calculated scattering coefficient.
- the light intensity detected by the light intensity detector 3 includes the influence of light scattering by blood lipids, and from this, the scattering coefficient ⁇ S ′ is to be calculated.
- the method described in Patent Document 2 International Publication No. 2014/0887825
- the present invention is to solve the problem that detection accuracy is insufficient because light that has actually passed through blood and light that has not passed through blood cannot be distinguished from detection light emitted from a living body.
- the scattering coefficient calculation unit 41 determines whether or not the light intensity detected by the light intensity detection unit 3 is transmitted through blood in the living body. The determination can also be automatically performed by a method such as using a computer having a predetermined program.
- the method for determining whether or not the detected light intensity is transmitted through the blood can be performed based on the knowledge found by the present inventors.
- light that has passed through the blood has a large absorption as well as scattering, and when measured at the same position from the light source, the intensity of the light that has passed through the blood is significantly attenuated compared to light that has not passed through the blood. It is possible to determine whether or not the light intensity of the detection light has passed through the blood by using the attenuation of the transmitted light intensity in the blood as an index.
- a specific example of determining whether or not the light transmitted through the blood using the attenuation of transmitted light intensity in blood as an index is, for example, light having a light intensity equal to or lower than a preset threshold for a plurality of detected light intensities.
- This is a method for discriminating that the light intensity is transmitted through blood in the living body.
- the threshold value for example, the light intensity of the light source and the distance from the light source to the detector are fixed, and the light intensity is measured by a plurality of irradiation units—light intensity detection units (also referred to as lines).
- the light transmitted through the blood has a large absorption in addition to the scattering, so that the light is attenuated.
- the location of the blood vessel can be specified, and in addition, when the blood passes through the blood at a specific irradiation part-light intensity detection part distance
- the light intensity and the light intensity when not transmitting through the blood can be obtained. Then, assuming that the light intensity when not transmitting through the blood is 100%, the light intensity of 70% or less may be determined as the light intensity transmitted through the blood, and the light intensity of 50% or less May be determined as the light intensity transmitted through the blood, and the light intensity of 40% or less may be determined as the light intensity transmitted through the blood, and the light intensity of 30% or less.
- Another method is to compare the detected multiple light intensities, and use a light with a low standardized light intensity normalized by the distance between the irradiation part and the light intensity detection part. This is a method for determining that When comparing the light intensities, the light intensity from the irradiating part is attenuated according to the distance, and therefore it is necessary to standardize the light intensity in consideration of the attenuation ratio due to the distance. Since the light transmitted through the blood is attenuated as described above, the light intensity after normalization is compared, and the light having a lower light intensity can be determined as the blood transmitted light. Note that the attenuation ratio depending on the distance of the light intensity can be derived in consideration of the method described in Patent Document 2.
- the threshold value of the attenuation ratio with the light intensity when not transmitting through the blood as described above as 100% may be set and used for discrimination.
- the above threshold value can be used as a specific threshold value.
- the detection of the light intensity may be 5 lines or more, 10 lines or more, or 15 lines or more.
- the light intensity at a specific distance is measured in advance a plurality of times as necessary to predict the light intensity not transmitted through the blood. Is a method of determining, comparing the predicted or determined reference light intensity not transmitted through blood with the measured light intensity, and if the light intensity is smaller than the reference light intensity, Can be determined. Furthermore, although it depends on the degree of accuracy of the required lipid concentration in the blood, it is generally related to the prediction or determination of the light intensity that is not transmitted through the blood. Since the scattering coefficient is known, the light intensity that does not pass through the blood can be calculated using the absorption coefficient / scattering coefficient. Also in these methods, the threshold value of the attenuation ratio with the light intensity when not transmitting through the blood as described above as 100% may be set and used for discrimination. In this case, the above threshold value can be used as a specific threshold value.
- the lipid concentration calculation unit 42 included in the calculation unit 4 calculates blood lipid concentration based on the scattering coefficient ⁇ S ′ calculated by the scattering coefficient calculation unit 41. Note that there is a correlation between the scattering coefficient ⁇ S ′ and the lipid concentration, and the lipid concentration is calculated based on the value of the scattering coefficient ⁇ S ′. In this embodiment, statistical data on the relationship between the scattering coefficient ⁇ S ′ and blood lipid concentration is taken in advance, and the actual blood lipid concentration is calculated by comparing the scattering coefficient ⁇ S ′ with the statistical data. To do.
- the measurement result obtained by measuring the blood lipid concentration of Mr. A by another blood lipid concentration measuring method such as blood sampling and the like was calculated.
- the statistical data of Mr. A can be created so that the concentration can be calculated.
- the statistical data of Mr. A may be created by calculating an error between the concentration obtained by the above and the concentration in the statistical data in the case of a general living body, and performing calibration to correct the error .
- the format of the statistical data is not particularly limited, and may be classified by gender, height, weight, BMI, etc., and may be calculated using a table, a graph, a functional expression, or the like. .
- concentration and turbidity are sometimes used interchangeably, and the concentration in the present invention includes the concept of turbidity. Therefore, the lipid concentration calculation means can calculate not only the concentration but also the number of particles per unit amount and formazine turbidity as the calculation result.
- FIG. 3 is a top schematic diagram (a), a cross-sectional schematic diagram (b), a top schematic diagram (c), and a positional relationship between a biological blood vessel and an irradiation unit and a light intensity detection unit of a non-invasive biological lipid measuring instrument; It is an upper surface schematic diagram (d). Since the apparatus disclosed in FIG. 3A calculates the scattering coefficient based on the distance ratio between the irradiation detection from the irradiation unit 12 to the light intensity detection unit 13, the irradiation unit 12 and the plurality of light intensity detection units 13 are linear. It is intended to exist in the form.
- the light intensity detection unit 13 may be disposed at a position away from the blood vessel 11, as shown in FIG. Moreover, since the position of the blood vessel 11 cannot always be confirmed through the skin depending on the color and constitution of the skin, there is a difficulty in positioning itself. Furthermore, even if the alignment is possible, it is difficult to grasp where the blood vessel 11 exists in the depth direction of the skin, and the light irradiated from the irradiation unit 12 as shown in FIG. The scattering propagation path 14 only needs to pass through the blood, but depending on the intensity and angle of incident light at the light source, the scattering propagation path may not pass through the blood. In the present embodiment, since it is determined whether or not the detection light detected by the light intensity detection unit 13 is transmitted through blood in the living body, the above problems are solved.
- FIG. 4 is a schematic top view (a) and a schematic top view (b) showing the positional relationship between the blood vessel of the living body and the irradiation unit and the light intensity detection unit of the noninvasive biological lipid measuring instrument.
- the positioning problem can be solved by the arrangement of the detector 13 as disclosed in FIG. In FIG. 4A, even if the light intensity detection unit 13 (for example, a plurality of light intensity detection units 13 existing on one straight line from the irradiation unit 12) is disposed outside the blood vessel, the light intensity detection unit 13 is constant from the irradiation unit 12. By disposing the plurality of light intensity detectors 13 in a fan shape at a distance, the scattered light transmitted through the blood can be reliably detected.
- the light intensity detection unit 13 for example, a plurality of light intensity detection units 13 existing on one straight line from the irradiation unit 12
- the arrangement range is not particularly limited, but from the viewpoint of obtaining detection light that has surely transmitted through the blood, the light intensity detection unit 13 and the irradiation unit located in the center of the fan shape It is preferable to deploy 30 degrees or more on both sides from the line connecting 12 to the surface, 45 degrees or more, or 60 degrees or more, or 75 degrees or more. Or 90 degrees or more.
- the light intensity detection unit 13 is formed in a two-dimensional array, so that scattered light transmitted through the blood can be obtained even if several light intensity detection units 13 are arranged outside the blood vessel. Can be reliably detected.
- the shape and size of the array formed by the light intensity detector 13 when arranged in an array are not particularly limited and are generally rectangular, but are not limited thereto. Also, the size is not particularly limited. For example, when a wearable device is assumed, the maximum length may be 1 cm or more, the maximum length may be 3 cm or more, the maximum length may be 5 cm or more, and the maximum length is It may be 10 cm or more.
- FIG. 5 is a top schematic diagram (a), a top schematic diagram (b), and a top schematic diagram (c) showing the positional relationship between a living body blood vessel and an irradiation unit and a light intensity detection unit of a noninvasive biological lipid measuring instrument.
- the light source 12 instead of the light intensity detector 13 may be disconnected from the blood vessel 11.
- the positioning problem can be solved by making the position or angle of the irradiation unit 12 movable in the vertical direction, for example.
- An example in which the irradiation unit 12 is movable includes, for example, a beam controller, but is not limited thereto.
- a plurality of irradiation units 12 can be arranged in a two-dimensional array.
- the shape and size of the array formed by the irradiation unit 12 when the light emitting units 12 are arranged in an array are not particularly limited and are generally rectangular, but are not limited thereto. Also, the size is not particularly limited. For example, when assuming a wearable device, the maximum length may be 1 cm or more, the maximum length may be 3 cm or more, the maximum length may be 5 cm or more, and the maximum length is It may be 10 cm or more.
- the alignment problem can be completely solved by adopting the embodiment shown in FIG. 6 in which both the irradiation unit 12 and the light intensity detection unit 13 are arranged in an array.
- the transmitted light in the blood attenuates as the distance between the irradiation unit 12 and the light intensity detection unit 13 increases. For this reason, the detection light detected from the light intensity detection unit 13 present at the position closest to the irradiation unit 12 has a certain intensity, and the light intensity detection present at the position farthest from the irradiation unit 12.
- the intensity of the detection light detected from the unit 13 is small, there are cases where the intensity range of the detection light does not fall within the detection range that can be measured by the same detector.
- the array formed by the light intensity detector 13 has a neutral density filter with a concentration gradient.
- the detection light intensity can be converged within the detection range that can be measured by the same detector.
- a filter that can cut a lot of light at a location close to the irradiation unit 12 and has a small amount of light cut at a location far from the irradiation unit 12 is used.
- the gradient of the filter with the density gradient an appropriate gradient can be determined by measuring the light intensity in advance without a filter and then dividing it back in the calculation.
- the condensing means 16 having an optical condensing function as shown in FIG. 7B, even if the detectable range immediately above the living body is large, the light is collected by the condensing means.
- the detected light can also be detected by the small light intensity detector 13.
- a specific example of the light collecting means 16 is a convex mirror, but is not particularly limited as long as it has a light collecting function.
- a method for measuring non-invasive biological lipids in an embodiment of the present invention includes an irradiation step of irradiating light at a predetermined light intensity from outside the living body to the living body, and the irradiation light in the irradiation step is in vivo.
- a non-invasive biological lipid that includes a step of determining whether or not the light is transmitted, and that calculates a light scattering coefficient determined to have passed through the blood in the living body by the step It is a method of measurement.
- the calculated scattering coefficient is used for calculating the lipid concentration in the lipid concentration calculating step.
- the irradiation step is a step of irradiating light from the irradiation unit toward the living body with a predetermined light intensity.
- the irradiation unit irradiates continuous light having a predetermined intensity from outside the body toward the inside of the body. By making the light irradiating the living body continuous light, the light intensity detected by the light intensity detector can be prevented from including the influence of attenuation due to time.
- the wavelength of light emitted from the irradiation unit is preferably 1400 nm or less in consideration of the wavelength range in which the light is absorbed by the plasma inorganic substance, and the wavelength at which the light is absorbed by the cellular components of blood. In consideration of the range, the thickness is more preferably 580 nm to 1400 nm.
- the light intensity detection step is a step in which the light intensity detection unit detects the light emitted in the irradiation step and emitted from the living body through scattering in the living body.
- the intensity of the light emitted from the irradiation unit is detected by the light detector of the light intensity detection unit.
- a light scattering coefficient in the living body is calculated based on the light intensity detected in the light intensity detection step.
- the details of the calculation of the light scattering coefficient can be referred to those described in Patent Document 2 (International Publication No. 2014/0887825).
- the calculated light scattering coefficient is sent to the lipid concentration calculating step. At this time, it is determined whether or not the light intensity detected by the light intensity detection step is transmitted through blood in the living body. By this discrimination step, it is possible to discriminate whether or not the detection light is transmitted through the blood without requiring strict alignment, so that lipid measurement of a living body can be performed more easily and accurately.
- the lipid concentration calculating step is a step of calculating the blood lipid concentration and the like based on the correlation between the blood lipid concentration and the scattering coefficient. Note that there are a plurality of methods for calculating the light scattering coefficient, as described in Patent Document 2 (International Publication No. 2014/0887825), and any method may be used.
- the calculated lipid concentration is compared with statistical data prepared in advance, and it is determined whether or not it is a normal value. If it is not a normal value, it can be determined that some abnormality may exist.
- the noninvasive biological lipid measuring instrument according to the embodiment of the present invention can be designed in a very small device, it can be used in a wearable device.
- the measuring instrument according to the present invention is applied to a digital wristwatch. Mounted and can measure blood lipid concentration when needed. Moreover, it can also be used like a thermometer as a home medical device.
- Non-invasive biological lipid measuring device 2 Irradiation part 3
- Light intensity detection part 4 Calculation part 41
- Scattering coefficient calculation part 42
- Lipid concentration calculation part 10 20 Living body 11, 21 Blood vessel 12, 22 Irradiation part 13, 23
- Light intensity detection part 14 Detection scattered light propagation path 15 Density filter with concentration gradient 16 Condensing means
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
本発明は、非侵襲で、生体内における血液中の脂質を測定することができる生体脂質計測器に関し、また、非侵襲で、生体内における血液中の脂質を測定することができる生体脂質計測方法に関する。 The present invention relates to a biological lipid measuring instrument that can measure lipid in blood in a living body non-invasively, and a biological lipid measuring method that can measure lipid in blood in a living body non-invasively About.
非侵襲の血中成分計測に関して、いくつかの技術が開発されてきた。
例えば特許文献1には、近赤外領域や、赤外領域の波長の光を音響光学可変振動フィルタによって出力して生体に照射し、非測定対象物を透過または反射した光を受光して得られた吸光スペクトルを解析・演算することにより非測定対象物の濃度を算出する装置に関する発明が開示されている。
Several techniques have been developed for non-invasive blood component measurement.
For example, in
また、特許文献2には、光を生体に照射して、生体から放出される光強度を検出し、該検出光の散乱係数を算出し、該散乱係数を用いることで生体内における脂質濃度を算出する装置に関する発明が開示されている。
上記特許文献2に開示の技術により、光学散乱を用いて、生体内の脂質を高精度に測定する道が拓かれ、容易に生体内の脂質濃度を計測できるようになり、代謝異常の検査などへの応用が期待されている。
一方で特許文献2に開示の技術では、生体から放出された検出光のうち、実際に血中を透過した光と透過していない光を区別することができない。そのため、照射部からの光が確実に血中を透過するように、照射部及び検出部の位置合わせが必要であるという課題があった。更に、位置合わせしようとしても、皮膚の色や体質によっては必ずしも血管の位置を皮膚越しに確認できるわけではないため、位置合わせ自体にも困難性が存在した。
The technique disclosed in the above-mentioned
On the other hand, the technique disclosed in
本発明者らは、上記課題を解決するために鋭意検討した結果、血中を透過した光は散乱に加えて吸光も大きく、光源から同じ位置で測定した場合に、血中を透過した光は血中を透過していない光と比較して著しく強度が減衰していることを見出した。そして、散乱係数を算出する際に、検出光が血中を透過しているか否かを判別し、血中を透過したと判別された光の散乱係数を算出することで、上記問題を解決できることに想到し、本発明を完成させた。 As a result of diligent studies to solve the above problems, the present inventors have found that light transmitted through the blood has a large absorption in addition to scattering, and when measured at the same position from the light source, the light transmitted through the blood is It was found that the intensity was remarkably attenuated compared to light that did not pass through the blood. Then, when calculating the scattering coefficient, it is possible to solve the above problem by determining whether or not the detection light is transmitted through the blood and calculating the scattering coefficient of the light determined to be transmitted through the blood. The present invention has been completed.
すなわち、本発明は以下を要旨とする。
(1)生体内における血液中の脂質を計測する非侵襲型生体脂質計測器であって、
生体外から生体内に向けて所定の光強度で光を照射する照射部と、
照射部からの照射光が生体内での散乱を経て、前記生体から放出される光強度を検出する光強度検出部と、
前記光強度検出部により検出された前記光強度に基づき前記生体内における光の散乱係数を算出する散乱係数算出部と、
前記算出された散乱係数に基づき脂質濃度を算出する脂質濃度算出部と、を有し、
前記散乱係数算出部は、前記光強度検出部により検出された前記光強度が、前記生体内の血中を透過しているか否かを判別し、前記生体内の血中を透過したと判別された光の散乱係数を算出する、
非侵襲型生体脂質計測器。
(2)前記散乱係数算出部は、検出した複数の光強度に対し、予め設定した閾値以下の光強度を有する光を、生体内の血中を透過した光強度であると判別する、(1)に記載の非侵襲型生体脂質計測器。
(3)前記散乱係数算出部は、検出した複数の光強度を比較し、照射部と検出部との距離により規格化した光強度が小さいものを、生体内の血中を透過した光強度であると判別する、(1)に記載の非侵襲型生体脂質計測器。
(4)前記照射部及び/又は前記光強度検出部が複数配置される、(1)から(3)のいずれかに記載の非侵襲型生体脂質計測器。
(5)前記光強度検出部が複数配置されており、かつ、前記複数の光強度検出部において検出される光強度が略同一となるように光量をカットするフィルタを有する、(1)から(4)のいずれかに記載の非侵襲型生体脂質計測器。
(6)前記照射部が照射光を変調可能であり、前記散乱係数算出部は照射光の変調に応じ散乱係数を算出可能である、(1)から(5)のいずれかに記載の非侵襲型生体脂質計測器。
That is, the gist of the present invention is as follows.
(1) A noninvasive living body lipid measuring instrument for measuring lipids in blood in a living body,
An irradiation unit that emits light at a predetermined light intensity from outside the living body toward the living body;
A light intensity detection unit that detects light intensity emitted from the living body through scattering of the irradiation light from the irradiation unit;
A scattering coefficient calculation unit that calculates a scattering coefficient of light in the living body based on the light intensity detected by the light intensity detection unit;
A lipid concentration calculator that calculates a lipid concentration based on the calculated scattering coefficient,
The scattering coefficient calculation unit determines whether or not the light intensity detected by the light intensity detection unit is transmitted through the blood in the living body, and is determined to have transmitted through the blood in the living body. Calculate the scattering coefficient of the light
Non-invasive biological lipid measuring instrument.
(2) The scattering coefficient calculation unit determines that the light having a light intensity equal to or lower than a preset threshold is the light intensity transmitted through the blood in the living body with respect to the plurality of detected light intensities. ) Non-invasive living body lipid measuring instrument.
(3) The scattering coefficient calculation unit compares a plurality of detected light intensities, and the light intensity normalized by the distance between the irradiation unit and the detection unit is the light intensity transmitted through the blood in the living body. The noninvasive living body lipid measuring device according to (1), which is determined to be present.
(4) The noninvasive biological lipid measuring instrument according to any one of (1) to (3), wherein a plurality of the irradiation units and / or the light intensity detection units are arranged.
(5) A plurality of the light intensity detectors are arranged, and a filter that cuts the amount of light so that the light intensities detected by the plurality of light intensity detectors are substantially the same (1) to (1) 4) The noninvasive biological lipid measuring instrument according to any one of the above.
(6) The non-invasive device according to any one of (1) to (5), wherein the irradiation unit can modulate the irradiation light, and the scattering coefficient calculation unit can calculate a scattering coefficient in accordance with the modulation of the irradiation light. Type biological lipid measuring instrument.
また、本発明の別の態様では、以下を要旨とする。
(7)生体内における血液中の脂質を計測する方法であって、
生体外から生体内に向けて所定の光強度で光を照射する照射ステップ、
前記照射ステップでの照射光が生体内での散乱を経て、前記生体から放出される光強度を検出する光強度検出ステップ、
前記光強度検出ステップにより検出された前記光強度に基づき前記生体内における光の散乱係数を算出する散乱係数算出ステップ、及び
前記算出された散乱係数に基づき脂質濃度を算出する脂質濃度算出ステップ、を有し、
前記散乱係数算出ステップは、前記光強度検出ステップにより検出された前記光強度が、前記生体内の血中を透過しているか否かを判別するステップを含み、該ステップにより前記生体内の血中を透過したと判別された光の散乱係数を算出する、
非侵襲型生体脂質を計測する方法。
Another aspect of the present invention is summarized as follows.
(7) A method for measuring lipids in blood in a living body,
An irradiation step of irradiating light at a predetermined light intensity from outside the living body toward the living body;
A light intensity detection step of detecting light intensity emitted from the living body through scattering in the living body of the irradiation light in the irradiation step;
A scattering coefficient calculating step for calculating a light scattering coefficient in the living body based on the light intensity detected by the light intensity detecting step; and a lipid concentration calculating step for calculating a lipid concentration based on the calculated scattering coefficient. Have
The scattering coefficient calculating step includes a step of determining whether or not the light intensity detected by the light intensity detecting step is transmitted through the blood in the living body, and the blood in the living body is determined by the step. Calculating the scattering coefficient of the light determined to have passed through,
A method for measuring non-invasive biological lipids.
本発明により、非侵襲型の生体脂質計測器において、厳密な位置合わせを必要とせず、血中を透過した検出光であるか否かを判別できるため、より簡易に且つ正確に生体の脂質計測が可能となる。
また、照射部及び/又は光強度検出部を複数にすることで、検出できる光強度の数(照射部-検出部のライン)が増えることから、散乱係数の算出において直線形変換を用いる場合には、その精度を著しく向上させることができる。
一方で、検出できる光強度の数が増えることから、直線形変換を用いずとも、例えばカーブフィッティングを用いて散乱係数を算出できる。そのため、より複雑な解析ができる。
According to the present invention, in a non-invasive biological lipid measuring instrument, it is possible to determine whether or not the detection light is transmitted through the blood without requiring precise alignment. Is possible.
In addition, by using a plurality of irradiation units and / or light intensity detection units, the number of light intensities that can be detected (irradiation unit-detection unit lines) increases. Therefore, when linear conversion is used in the calculation of the scattering coefficient. Can significantly improve its accuracy.
On the other hand, since the number of light intensities that can be detected increases, the scattering coefficient can be calculated using, for example, curve fitting without using linear transformation. Therefore, more complicated analysis can be performed.
以下、本発明の実施の形態を詳細に説明する。以下に記載する構成要件の説明は、本発明の実施形態の一例(代表例)であり、本発明はその要旨を超えない限り、これらの内容に限定されず、種々の変更をして実施することができる。また、理解のため、図面の一部を強調したり拡大したりする場合もあるが、あくまでの理解のための拡大・強調である。 Hereinafter, embodiments of the present invention will be described in detail. The description of the constituent elements described below is an example (representative example) of an embodiment of the present invention, and the present invention is not limited to these contents unless the gist of the present invention is exceeded, and various modifications are performed. be able to. In addition, a part of the drawing may be emphasized or enlarged for the sake of understanding, but this is merely an enlargement / emphasis for understanding.
本実施形態に係る非侵襲型生体脂質計測器の模式図を図1に示す。非侵襲型生体脂質計測器1は、生体外から生体に向けて光を照射する照射部2と、該照射部からの照射光が生体内での散乱を経て、生体から放出される光強度を検出する光強度検出部3と、この光強度検出部により検出された前記光強度に基づき生体内における光の散乱係数μS’を算出する散乱係数算出部41、及び散乱係数算出部41により算出された光の散乱係数μS’に基づき生体内における脂質濃度を算出する脂質濃度算出部42、を含む演算部4を有する。
A schematic diagram of a non-invasive biological lipid measuring apparatus according to the present embodiment is shown in FIG. The non-invasive living body
照射部2は、図1に示すように、生体外から生体に向けて、所定の照射位置に光を照射するものであり、光を照射するための光源を有している。前記光源は、その波長範囲が血漿中の水やヘモグロビンなどの物質によって光が大きく吸収される波長範囲以外となるように調整されている。
なお、本発明において血中とは、静脈、動脈にかぎらず、毛細血管をも含む血管中を意味するが、静脈や動脈等、毛細血管以外の比較的太い血管であることが好ましい。
As shown in FIG. 1, the irradiating
In the present invention, blood means not only veins and arteries but also blood vessels including capillaries, but is preferably relatively thick blood vessels other than capillaries such as veins and arteries.
また、血漿中の物質により光を吸収する波長範囲とは、主に、血漿中の水やヘモグロビンによる光の吸収が強い範囲を示す。
即ち、光源として用いられる波長範囲は、血漿中の水により光が吸収される波長範囲を考慮して1400nm以下とするのが好ましく、さらに、ヘモグロビンによって光が吸収される波長範囲を考慮して580nm以上1400nm以下とするのがより好ましい。
In addition, the wavelength range in which light is absorbed by substances in plasma mainly indicates a range in which light absorption by water or hemoglobin in plasma is strong.
That is, the wavelength range used as a light source is preferably 1400 nm or less in consideration of the wavelength range in which light is absorbed by water in plasma, and further, 580 nm in consideration of the wavelength range in which light is absorbed by hemoglobin. The thickness is more preferably 1400 nm or less.
このように、光源として用いられる波長範囲を上記範囲とすることにより、後述する光強度検出部3により検出される光において、血漿中の無機物による光の吸収の影響および血液の細胞成分による光の吸収の影響を抑制することが可能となる。これにより、吸収による光エネルギー損失は小さくなる。
In this way, by setting the wavelength range used as the light source to the above range, in the light detected by the
また、本実施形態の照射部2は、後述する散乱係数算出部41による散乱係数μS’の算出方法に応じて、光の連続的な照射や光のパルス状の照射等の光を照射する時間長さを任意に調整することができ、かつ照射する光の強度または光の位相を任意に変調することができる。
特に、光源と生体との間に距離が存在する場合には、外部からの光を遮光する手段を備えることが好ましいが、このような手段を備えない場合であっても、照射部2を変調可能とすることで、光強度検出部3において、外部からの光と照射部2からの光とを区別して検出することができる。また、そのような場合、前記散乱係数算出部41は、照射光の変調に応じ散乱係数を算出可能であることが必要である。
Further, the
In particular, when there is a distance between the light source and the living body, it is preferable to provide means for shielding light from the outside, but even if such means is not provided, the
図1においては、照射部2は1つのみ記載されているが、複数存在してもよい。照射部が複数存在することで、光源の光強度や、光照射部と光強度検出部との距離を変化させた複数のデータを取得することが容易となり、散乱係数の算出において直線形変換を用いる場合には、その精度を著しく向上させることが可能となり、一方で、直線形変換を用いずとも、例えばカーブフィッティングを用いて散乱係数を算出できることとなる。
In FIG. 1, only one
光強度検出部3は、光を受光してその光強度を検出するものであり、照射部からの照射光が生体内での散乱を経て、生体から生体外に放出される光を光検出器で受光し、その光強度を検出できるようになっている。また、複数の光強度検出部3を用いる場合は、照射位置を中心として各々異なる距離に設置されてもよく、同一の距離において扇形に設置されてもよい。図1では、照射位置から所定の間隔で、同一面上でかつ直線状に光強度検出部が順に並べられ得るが、これに限られない。
The light
図1では、光を生体に照射する照射位置と、生体から放出される光強度を検出する検出位置との間に所定の距離を設ける。これにより、照射した光が生体表面および表面近傍の散乱体により反射され、直接的に生体から放出される光の影響を抑制できる。また照射光が血液や脂質が存在する深さに達したのち、血中脂質による散乱を経て生体から放出される後方散乱光の、光強度を計測することができる。
一方で、生体から放出された検出光のうち、実際に血中を透過した光と透過していない光を区別しない場合には、正確な生体脂質濃度を取得できない場合がある。
In FIG. 1, a predetermined distance is provided between an irradiation position for irradiating the living body with light and a detection position for detecting the light intensity emitted from the living body. Thereby, the irradiated light is reflected by the scatterer in the living body surface and the vicinity of the surface, and the influence of the light emitted directly from the living body can be suppressed. Moreover, after the irradiation light reaches the depth where blood or lipid exists, the light intensity of the backscattered light emitted from the living body through scattering by blood lipid can be measured.
On the other hand, if the detection light emitted from the living body does not distinguish between light that has actually passed through blood and light that has not passed through, it may not be possible to obtain an accurate biological lipid concentration.
なお、複数の検出位置を設ける場合の配列は、照射位置を中心として各々異なる距離に配置されるのであれば直線状に限定されるものではなく、円状、波状、ジグザグ状、扇形状、更には2次元に広げたアレイ状など、適宜選択することができる。また、照射位置から検出位置までの照射検出間距離、検出位置同士の間隔は、一定の間隔に限定されるものではなく、適宜選択されるものである。 The arrangement in the case of providing a plurality of detection positions is not limited to a straight line as long as they are arranged at different distances around the irradiation position, but are not limited to a circular shape, a wavy shape, a zigzag shape, a fan shape, Can be selected as appropriate, such as a two-dimensional array. Moreover, the distance between irradiation detection from an irradiation position to a detection position, and the space | interval of detection positions are not limited to a fixed space | interval, but are selected suitably.
演算部4のうち、散乱係数算出部41は、光強度検出部3により検出された光強度に基づき生体内における光の散乱係数μS’を算出する。そして、演算部4のうち、脂質濃度算出部42では、算出された散乱係数を用い、脂質濃度を算出する。上述のとおり、光強度検出部3により検出された光強度は、血中脂質による光の散乱の影響が含まれており、そのことから散乱係数μS’を算出しようとするものである。
散乱係数μS’の算出については、特許文献2(国際公開第2014/087825号)に記載の方法をそのまま適用することが可能である。
Of the
For the calculation of the scattering coefficient μ S ′, the method described in Patent Document 2 (International Publication No. 2014/0887825) can be applied as it is.
一方で本発明は、生体から放出された検出光のうち、実際に血中を透過した光と透過していない光を区別することができないため検出精度が不十分であるという問題を解決すべく、散乱係数算出部41において、前記光強度検出部3により検出された前記光強度が、前記生体内の血中を透過しているか否かを判別する。判別は、所定のプログラムを備えたコンピュータを用いるなどの方法で、自動的に行うこともできる。
On the other hand, the present invention is to solve the problem that detection accuracy is insufficient because light that has actually passed through blood and light that has not passed through blood cannot be distinguished from detection light emitted from a living body. The scattering coefficient calculation unit 41 determines whether or not the light intensity detected by the light
検出された光強度が血中を透過しているか否かの判別の方法は、今回本発明者らが見出した知見に基づき行うことができる。即ち、血中を透過した光は散乱に加えて吸光も大きく、光源から同じ位置で測定した場合に、血中を透過した光は血中を透過していない光と比較して著しく強度が減衰している、という知見を利用し、血中における透過光強度の減衰を指標として、検出光の光強度が血中を透過したか否かを判別できる。 The method for determining whether or not the detected light intensity is transmitted through the blood can be performed based on the knowledge found by the present inventors. In other words, light that has passed through the blood has a large absorption as well as scattering, and when measured at the same position from the light source, the intensity of the light that has passed through the blood is significantly attenuated compared to light that has not passed through the blood. It is possible to determine whether or not the light intensity of the detection light has passed through the blood by using the attenuation of the transmitted light intensity in the blood as an index.
血中における透過光強度の減衰を指標として血中を透過したか否かを判別する具体例は、例えば、検出した複数の光強度に対し、予め設定した閾値以下の光強度を有する光を、生体内の血中を透過した光強度であると判別する方法である。
予め閾値を設定する方法としては、例えば、光源の光強度及び光源から検出器までの距離を一定とし、複数の照射部-光強度検出部(ラインともいう)で光強度を測定する。ここで、血中を透過した光は、散乱に加えて吸収も大きいことから、光の減衰が生じる。そのため、複数ラインで光強度を測定し、その強度を比較することで、血管の場所を特定することができ、加えて、特定の照射部-光強度検出部の距離における血中を透過した場合の光強度及び血中を透過しない場合の光強度を求めることができる。そして、血中を透過しない場合の光強度を100%とし、70%以下の光強度のものを、血中を透過した光強度であると判断してもよく、50%以下の光強度のものを、血中を透過した光強度であると判断してもよく、40%以下の光強度のものを、血中を透過した光強度であると判断してもよく、30%以下の光強度のものを、血中を透過した光強度であると判断してもよく、20%以下の光強度のものを、血中を透過した光強度であると判断してもよく、10%以下の光強度のものを、血中を透過した光強度であると判断してもよい。この数値は、要求される血中脂質濃度の正確性により、適宜決定できる。
A specific example of determining whether or not the light transmitted through the blood using the attenuation of transmitted light intensity in blood as an index is, for example, light having a light intensity equal to or lower than a preset threshold for a plurality of detected light intensities. This is a method for discriminating that the light intensity is transmitted through blood in the living body.
As a method of setting the threshold value in advance, for example, the light intensity of the light source and the distance from the light source to the detector are fixed, and the light intensity is measured by a plurality of irradiation units—light intensity detection units (also referred to as lines). Here, the light transmitted through the blood has a large absorption in addition to the scattering, so that the light is attenuated. Therefore, by measuring the light intensity with multiple lines and comparing the intensities, the location of the blood vessel can be specified, and in addition, when the blood passes through the blood at a specific irradiation part-light intensity detection part distance The light intensity and the light intensity when not transmitting through the blood can be obtained. Then, assuming that the light intensity when not transmitting through the blood is 100%, the light intensity of 70% or less may be determined as the light intensity transmitted through the blood, and the light intensity of 50% or less May be determined as the light intensity transmitted through the blood, and the light intensity of 40% or less may be determined as the light intensity transmitted through the blood, and the light intensity of 30% or less. May be judged as the light intensity transmitted through the blood, and those having a light intensity of 20% or less may be judged as the light intensity transmitted through the blood. You may judge that the thing of light intensity is the light intensity which permeate | transmitted in the blood. This numerical value can be appropriately determined depending on the accuracy of the required blood lipid concentration.
また、別の方法としては、検出した複数の光強度を比較し、照射部と光強度検出部との距離により規格化した規格光強度が小さいものを、生体内の血中を透過した光強度であると判別する方法である。光強度の比較の際には、照射部からの光強度は距離に応じて減衰するため、距離による減衰割合を考慮して光強度を規格化することが必要である。そして、上述のとおり血中を透過した光は光の減衰が生じるため、規格化後の光強度を比較し、光強度のより小さいものを血中透過光と判別することができる。
なお、光強度の距離による減衰割合については、特許文献2に記載の方法などを参酌し、導くことができる。
また、この方法においても、上記記載したような血中を透過しない場合の光強度を100%とした減衰割合の閾値を設定し、判別に用いてもよい。その場合の具体的な閾値については、上述の閾値を援用できる。
この方法では、光強度の検出は、多く(のライン数)行うほど血中透過判別精度が向上する。数の制限は特段ないが、例えば光強度の検出は、5ライン以上であってもよく、10ライン以上であってもよく、15ライン以上であってもよい。
Another method is to compare the detected multiple light intensities, and use a light with a low standardized light intensity normalized by the distance between the irradiation part and the light intensity detection part. This is a method for determining that When comparing the light intensities, the light intensity from the irradiating part is attenuated according to the distance, and therefore it is necessary to standardize the light intensity in consideration of the attenuation ratio due to the distance. Since the light transmitted through the blood is attenuated as described above, the light intensity after normalization is compared, and the light having a lower light intensity can be determined as the blood transmitted light.
Note that the attenuation ratio depending on the distance of the light intensity can be derived in consideration of the method described in
Also in this method, the threshold value of the attenuation ratio with the light intensity when not transmitting through the blood as described above as 100% may be set and used for discrimination. In this case, the above threshold value can be used as a specific threshold value.
In this method, as the light intensity is detected more (the number of lines), blood permeation discrimination accuracy is improved. Although the number is not particularly limited, for example, the detection of the light intensity may be 5 lines or more, 10 lines or more, or 15 lines or more.
その他の方法としては、血管が通っていない部分(毛細血管は考慮せず)において、特定距離における光強度を予め、必要に応じ複数回測定し、血中を透過していない光強度を予測乃至は決定する方法であり、当該予測乃至は決定した血中を透過していない基準光強度と、測定した光強度とを比較し、光強度が基準光強度よりも小さい場合、血中透過光と判別することができる。
更に、要求される血中脂質濃度の正確性の程度にもよるが、血中を透過していない光強度の予測乃至は決定に関し、一般的に人体の血管が通っていない部分の吸光係数・散乱係数は知られていることから、吸光係数・散乱係数を用い、血中を透過していない光強度を算出することもできる。
また、これらの方法においても、上記記載したような血中を透過しない場合の光強度を100%とした減衰割合の閾値を設定し、判別に用いてもよい。その場合の具体的な閾値については、上述の閾値を援用できる。
As another method, in a portion where blood vessels do not pass (capillary blood vessels are not considered), the light intensity at a specific distance is measured in advance a plurality of times as necessary to predict the light intensity not transmitted through the blood. Is a method of determining, comparing the predicted or determined reference light intensity not transmitted through blood with the measured light intensity, and if the light intensity is smaller than the reference light intensity, Can be determined.
Furthermore, although it depends on the degree of accuracy of the required lipid concentration in the blood, it is generally related to the prediction or determination of the light intensity that is not transmitted through the blood. Since the scattering coefficient is known, the light intensity that does not pass through the blood can be calculated using the absorption coefficient / scattering coefficient.
Also in these methods, the threshold value of the attenuation ratio with the light intensity when not transmitting through the blood as described above as 100% may be set and used for discrimination. In this case, the above threshold value can be used as a specific threshold value.
演算部4に含まれる脂質濃度算出部42は、散乱係数算出部41により算出された散乱係数μS’に基づいて血中脂質の濃度を算出するものである。なお、散乱係数μS’と脂質濃度とは相関があり、散乱係数μS’の値に基づいて脂質濃度を算出するものである。本実施形態では、予め散乱係数μS’と血中脂質濃度との関係について統計データを取り、散乱係数μS’と、前記統計データとを比較することにより、実際の血中脂質濃度を算出する。
The lipid concentration calculation unit 42 included in the
例えば、特定の生体A氏の血中脂質濃度を計測対象とする場合は、A氏の血中脂質濃度を採血などの他の血中脂質濃度計測方法等により計測した計測結果と、算出された散乱係数μS’とを比較して、A氏個人の統計データを作成して、濃度を算出できるようにすることができる。
若しくは、A氏の血中脂質の濃度を他の血中脂質の濃度の測定方法等により測定した測定結果と、検出された光強度より得られた濃度の測定結果とを比較して、その比較により得られた濃度と、一般的な生体の場合の前記統計データにおける濃度との誤差を算出し、その誤差を修正するキャリブレーションをすることで、A氏個人の統計データを作成してもよい。
For example, when the blood lipid concentration of a specific living body Mr. A is to be measured, the measurement result obtained by measuring the blood lipid concentration of Mr. A by another blood lipid concentration measuring method such as blood sampling and the like was calculated. By comparing with the scattering coefficient μ S ′, the statistical data of Mr. A can be created so that the concentration can be calculated.
Or, compare the measurement result of Mr. A's blood lipid concentration by other blood lipid concentration measurement methods, etc. with the measurement result of the concentration obtained from the detected light intensity, and compare The statistical data of Mr. A may be created by calculating an error between the concentration obtained by the above and the concentration in the statistical data in the case of a general living body, and performing calibration to correct the error .
なお、統計データの形式は特に限定されるものではなく、例えば、性別、身長、体重、BMI等で分類されていてもよく、表やグラフ、関数式等を用いて算出できるようにしてもよい。
また、臨床現場において、濃度と濁度とは同義で使われることがあり、本発明における濃度には濁度の概念も含まれる。よって、脂質濃度算出手段は、その算出結果として、濃度のみならず単位量当たりの粒子数やホルマジン濁度とすることができる。
Note that the format of the statistical data is not particularly limited, and may be classified by gender, height, weight, BMI, etc., and may be calculated using a table, a graph, a functional expression, or the like. .
In clinical practice, concentration and turbidity are sometimes used interchangeably, and the concentration in the present invention includes the concept of turbidity. Therefore, the lipid concentration calculation means can calculate not only the concentration but also the number of particles per unit amount and formazine turbidity as the calculation result.
以下、本発明の実施形態に係る非侵襲型生体脂質計測器について、図面を用いて更に詳細に説明する。
図3は、生体の血管及び非侵襲型生体脂質計測器の照射部及び光強度検出部の位置関係を示す上面模式図(a)、断面模式図(b)、上面模式図(c)、及び上面模式図(d)である。
図3(a)が開示する装置は、照射部12から光強度検出部13までの照射検出間距離比に基づいて散乱係数を算出するため、照射部12と複数の光強度検出部13が直線状に存在することを意図している。しかしながら、照射部12と光強度検出部13の設定によっては、図3(c)に示すように、血管11から外れた位置に光強度検出部13が配置される場合も考えられる。
また、皮膚の色や体質によっては必ずしも血管11の位置を皮膚越しに確認できるわけではないため、位置合わせ自体にも困難性が存在した。
更に、仮に位置合わせができたとしても、皮膚の深さ方向についてどの位置に血管11が存在するかを把握することは難しく、図3(b)のように照射部12から照射された光の散乱伝搬経路14が血中を通過すればよいが、光源における入射光の強さや角度によっては、散乱伝搬経路が血中を通過しない場合も考えられる。
本実施形態では、光強度検出部13で検出される検出光が生体内の血中を透過しているか否かを判別することから、上記のような問題点は解決される。
Hereinafter, the noninvasive biological lipid measuring device according to the embodiment of the present invention will be described in more detail with reference to the drawings.
FIG. 3 is a top schematic diagram (a), a cross-sectional schematic diagram (b), a top schematic diagram (c), and a positional relationship between a biological blood vessel and an irradiation unit and a light intensity detection unit of a non-invasive biological lipid measuring instrument; It is an upper surface schematic diagram (d).
Since the apparatus disclosed in FIG. 3A calculates the scattering coefficient based on the distance ratio between the irradiation detection from the
Moreover, since the position of the
Furthermore, even if the alignment is possible, it is difficult to grasp where the
In the present embodiment, since it is determined whether or not the detection light detected by the light
一方で、図4は、生体の血管及び非侵襲型生体脂質計測器の照射部及び光強度検出部の位置関係を示す上面模式図(a)、及び上面模式図(b)であり、図4に開示するような検出部13の配置により、位置合わせの問題を解決することができる。
図4(a)では、光強度検出部13(例えば照射部12からの1本の直線上に存在する複数の光強度検出部13)が血管外に配置されても、照射部12から一定の距離において複数の光強度検出部13が扇形に配置されることで、血中を透過した散乱光を確実に検出することができる。光強度検出部13を扇形に配置する場合には、配置範囲は特段限定されないが、確実に血中を透過した検出光を得る観点から、扇形の中央に位置する光強度検出部13と照射部12とを結ぶ線より、両側に30度以上展開して配置することが好ましく、45度以上展開して配置してもよく、60度以上展開して配置してもよく、75度以上展開して配置してもよく、90度以上展開して配置してもよい。
On the other hand, FIG. 4 is a schematic top view (a) and a schematic top view (b) showing the positional relationship between the blood vessel of the living body and the irradiation unit and the light intensity detection unit of the noninvasive biological lipid measuring instrument. The positioning problem can be solved by the arrangement of the
In FIG. 4A, even if the light intensity detection unit 13 (for example, a plurality of light
また、図4(b)のように、光強度検出部13を二次元アレイ状とすることで、いくつかの光強度検出部13が血管外に配置されても、血中を透過した散乱光を確実に検出することができる。アレイ状に配置する場合の光強度検出部13が形成するアレイの形状、大きさは特段限定されず、一般的に矩形であるがこれに限定されない。また、大きさも特に限定されないが、例えばウエアラブルデバイスを想定する場合、最大長が1cm以上であってよく、最大長が3cm以上であってよく、最大長が5cm以上であってよく、最大長が10cm以上であってよい。
In addition, as shown in FIG. 4B, the light
他方、図5は、生体の血管及び非侵襲型生体脂質計測器の照射部及び光強度検出部の位置関係を示す上面模式図(a)、上面模式図(b)、及び上面模式図(c)であり、図3(d)に示すように、光強度検出部13ではなく光源12が血管11から外れることもあり得る。このような場合には、図5(a)に示すように、照射部12の位置あるいは角度を例えば上下方向に可動とすることで、位置合わせの問題を解決することができる。照射部12を可動とする例としては、例えばビームコントローラーを搭載することがあげられるがこれに限られない。
また、図5(b)に示すように、照射部12が上下方向に列を作るように、複数並べて配置してもよい。
更に、図5(c)に示すように、照射部12を二次元アレイ状に複数配置することもできる。光射部12をアレイ状に配置する場合の照射部12が形成するアレイの形状、大きさは特段限定されず、一般的に矩形であるがこれに限定されない。また、大きさも特に限定されないが、例えばウエアラブルデバイスを想定する場合、最大長が1cm以上であってよく、最大長が3cm以上であってよく、最大長が5cm以上であってよく、最大長が10cm以上であってよい。
On the other hand, FIG. 5 is a top schematic diagram (a), a top schematic diagram (b), and a top schematic diagram (c) showing the positional relationship between a living body blood vessel and an irradiation unit and a light intensity detection unit of a noninvasive biological lipid measuring instrument. As shown in FIG. 3D, the
Moreover, as shown in FIG.5 (b), you may arrange in multiple numbers so that the
Furthermore, as shown in FIG. 5C, a plurality of
なお、照射部12、光強度検出部13ともにアレイ状に配置する図6に示す実施形態にすることで、位置合わせの問題は完全に解決可能である。
The alignment problem can be completely solved by adopting the embodiment shown in FIG. 6 in which both the
また、図4(a)及び(b)に示すように光強度検出部13が複数ある場合、又は、図5(b)及び(c)に示すように、照射部12が複数ある場合、照射部12と光強度検出部13との間の距離が複数存在することとなる。一般的に血中透過光は、照射部12と光強度検出部13との間の距離が大きくなるにつれて減衰する。そのため、照射部12との距離が最も近い位置に存在する光強度検出部13から検出される検出光は、その強度がある程度大きく、照射部12との距離が最も遠い位置に存在する光強度検出部13から検出される検出光はその強度が小さくなることから、検出光の強度範囲が、同一の検出器で測定可能な検出範囲内に納まらない場合が存在する。
このような場合には、例えば光強度検出部13がアレイ状に配置されている場合、図7(a)に示すように、光強度検出部13により形成されるアレイに濃度勾配付き減光フィルタ15を配置することで、同一の検出器で測定可能な検出範囲内に検出光強度を収束させることができる。具体的には照射部12に近い箇所では多くの光をカットでき、遠い箇所では光のカット量が少ないフィルタを用いる。なお、濃度勾配付きフィルタの勾配については、予めフィルタなしで光強度を測定し、その後計算上にて割り戻すことで、適切な勾配を決定することができる。
Further, when there are a plurality of light
In such a case, for example, when the
また、光強度検出部13をアレイ状に配置すると、複数の光強度検出部13が必要となるため、デバイスが物理的に大きくなる傾向にある。このような場合には、図7(b)のように光学的に集光機能を有する集光手段16を用いることで、生体直上における検出可能な範囲は大きくても、集光手段により集約された検出光は、小さな光強度検出部13でも検出可能となる。集光手段16の具体例としては、凸面ミラーなどがあげられるが、集光機能を有するものであれば、特段限定されない。
Further, when the
以下、本発明の別の実施形態である、非侵襲型の生体脂質を計測する方法について説明する。
本発明の実施形態における非侵襲型の生体脂質を計測する方法は、生体外から生体内に向けて所定の光強度で光を照射する照射ステップ、前記照射ステップでの照射光が生体内での散乱を経て、前記生体から放出される光強度を検出する光強度検出ステップ、前記光強度検出ステップにより検出された前記光強度に基づき前記生体内における光の散乱係数を算出する散乱係数算出ステップ、及び前記算出された散乱係数に基づき脂質濃度を算出する脂質濃度算出ステップを有し、前記散乱係数算出ステップは、前記光強度検出ステップにより検出された前記光強度が、前記生体内の血中を透過しているか否かを判別するステップを含み、該ステップにより前記生体内の血中を透過したと判断された光の散乱係数を算出する、非侵襲型生体脂質を計測する方法である。算出された散乱係数は、脂質濃度算出ステップにおいて、脂質濃度を算出するのに使用される。以下、順にステップを追って説明する。
Hereinafter, a method for measuring non-invasive biological lipids, which is another embodiment of the present invention, will be described.
A method for measuring non-invasive biological lipids in an embodiment of the present invention includes an irradiation step of irradiating light at a predetermined light intensity from outside the living body to the living body, and the irradiation light in the irradiation step is in vivo. A light intensity detecting step for detecting light intensity emitted from the living body through scattering, a scattering coefficient calculating step for calculating a light scattering coefficient in the living body based on the light intensity detected by the light intensity detecting step; And a lipid concentration calculating step for calculating a lipid concentration based on the calculated scattering coefficient, wherein the scattering coefficient calculating step is configured such that the light intensity detected by the light intensity detecting step is measured in the blood in the living body. A non-invasive biological lipid that includes a step of determining whether or not the light is transmitted, and that calculates a light scattering coefficient determined to have passed through the blood in the living body by the step It is a method of measurement. The calculated scattering coefficient is used for calculating the lipid concentration in the lipid concentration calculating step. Hereinafter, steps will be described in order.
照射ステップは、照射部から所定の光強度で生体内に向けて光を照射するステップである。照射部は所定の強度の連続光を体外から体内に向けて照射する。生体に照射する光を連続光とすることで、光強度検出部により検出される光強度が、時間による減衰の影響を含まれないようにすることができる。
また、照射部から照射する光は、波長範囲が、血漿の無機物により光が吸収される波長範囲を考慮して1400nm以下とするのが好ましく、さらに、血液の細胞成分によって光が吸収される波長範囲を考慮して580nm~1400nmとするのがより好ましい。
The irradiation step is a step of irradiating light from the irradiation unit toward the living body with a predetermined light intensity. The irradiation unit irradiates continuous light having a predetermined intensity from outside the body toward the inside of the body. By making the light irradiating the living body continuous light, the light intensity detected by the light intensity detector can be prevented from including the influence of attenuation due to time.
In addition, the wavelength of light emitted from the irradiation unit is preferably 1400 nm or less in consideration of the wavelength range in which the light is absorbed by the plasma inorganic substance, and the wavelength at which the light is absorbed by the cellular components of blood. In consideration of the range, the thickness is more preferably 580 nm to 1400 nm.
光強度検出ステップでは、照射ステップで照射した光であって生体内での散乱を経て生体から放出された光を、光強度検出部で検出するステップである。光強度検出部の光検出器により、照射部から照射された光の強度が検出される。 The light intensity detection step is a step in which the light intensity detection unit detects the light emitted in the irradiation step and emitted from the living body through scattering in the living body. The intensity of the light emitted from the irradiation unit is detected by the light detector of the light intensity detection unit.
散乱係数算出ステップでは、前記光強度検出ステップにより検出された前記光強度に基づき前記生体内における光の散乱係数を算出する。光の散乱係数の算出の詳細は特許文献2(国際公開第2014/087825号)に記載されたものを参照することができる。算出された光の散乱係数は、脂質濃度算出ステップへと送られる。また、この際に、光強度検出ステップにより検出された光強度が、生体内の血中を透過しているか否かを判別する。この判別ステップにより、厳密な位置合わせを必要とせず、血中を透過した検出光であるか否かを判別できるため、より簡易に且つ正確に生体の脂質計測が可能となる。
そして、脂質濃度算出ステップは、血中脂質濃度と散乱係数とが相関関係を有することに基づき、血中脂質の濃度等を算出するステップである。
なお、光の散乱係数を算出する方法は、特許文献2(国際公開第2014/087825号)に記載されているように複数種類存在し、どの手法を用いてもよい。
In the scattering coefficient calculation step, a light scattering coefficient in the living body is calculated based on the light intensity detected in the light intensity detection step. The details of the calculation of the light scattering coefficient can be referred to those described in Patent Document 2 (International Publication No. 2014/0887825). The calculated light scattering coefficient is sent to the lipid concentration calculating step. At this time, it is determined whether or not the light intensity detected by the light intensity detection step is transmitted through blood in the living body. By this discrimination step, it is possible to discriminate whether or not the detection light is transmitted through the blood without requiring strict alignment, so that lipid measurement of a living body can be performed more easily and accurately.
The lipid concentration calculating step is a step of calculating the blood lipid concentration and the like based on the correlation between the blood lipid concentration and the scattering coefficient.
Note that there are a plurality of methods for calculating the light scattering coefficient, as described in Patent Document 2 (International Publication No. 2014/0887825), and any method may be used.
算出された脂質濃度は、予め準備された統計データと比較して、正常値であるか否かを判断し、正常値ではない場合には、何らかの異常が存在し得ると判断できる。 The calculated lipid concentration is compared with statistical data prepared in advance, and it is determined whether or not it is a normal value. If it is not a normal value, it can be determined that some abnormality may exist.
本発明の実施形態に係る非侵襲型生体脂質計測器は、非常に小型のデバイス設計が可能であることから、ウエアラブル型デバイスでの活用が想定され、例えばデジタル腕時計に本発明に係る計測器を搭載し、血中脂質濃度を必要時に測定することができる。また、家庭用医療デバイスとして、体温計などと同じように使用することもできる。 Since the noninvasive biological lipid measuring instrument according to the embodiment of the present invention can be designed in a very small device, it can be used in a wearable device. For example, the measuring instrument according to the present invention is applied to a digital wristwatch. Mounted and can measure blood lipid concentration when needed. Moreover, it can also be used like a thermometer as a home medical device.
他方、図8(a)に示すような、医療機関用の大型デバイスに適用することも可能であり、図8(b)に示すように、非接触型のデバイスに適用することも可能である。ただし、非接触型のデバイスに適用する場合、他の光源からのノイズを低減するために、光の強度や位相等を変調することが必要となる。 On the other hand, it can be applied to a large-sized device for a medical institution as shown in FIG. 8A, and can also be applied to a non-contact type device as shown in FIG. 8B. . However, when applied to a non-contact type device, in order to reduce noise from other light sources, it is necessary to modulate the intensity and phase of light.
1 非侵襲型生体脂質計測器
2 照射部
3 光強度検出部
4 演算部
41 散乱係数算出部
42 脂質濃度算出部
10、20 生体
11、21 血管
12、22 照射部
13、23 光強度検出部
14 検出散乱光の伝搬経路
15 濃度勾配付き減光フィルタ
16 集光手段
DESCRIPTION OF
Claims (7)
生体外から生体内に向けて所定の光強度で光を照射する照射部と、
前記照射部からの照射光が生体内での散乱を経て、生体から放出される光強度を検出する光強度検出部と、
前記光強度検出部により検出された前記光強度に基づき前記生体内における光の散乱係数を算出する散乱係数算出部と、
前記算出された散乱係数に基づき脂質濃度を算出する脂質濃度算出部と、を有し、
前記散乱係数算出部は、前記光強度検出部により検出された前記光強度が、前記生体内の血中を透過しているか否かを判別し、前記生体内の血中を透過したと判別された光の散乱係数を算出する、
非侵襲型生体脂質計測器。 A non-invasive biological lipid measuring instrument for measuring lipids in blood in a living body,
An irradiation unit that emits light at a predetermined light intensity from outside the living body toward the living body;
A light intensity detection unit that detects light intensity emitted from the living body through scattering of the irradiation light from the irradiation unit;
A scattering coefficient calculation unit that calculates a scattering coefficient of light in the living body based on the light intensity detected by the light intensity detection unit;
A lipid concentration calculator that calculates a lipid concentration based on the calculated scattering coefficient,
The scattering coefficient calculation unit determines whether or not the light intensity detected by the light intensity detection unit is transmitted through the blood in the living body, and is determined to have transmitted through the blood in the living body. Calculate the scattering coefficient of the light
Non-invasive biological lipid measuring instrument.
生体外から生体内に向けて所定の光強度で光を照射する照射ステップ、
前記照射ステップでの照射光が生体内での散乱を経て、前記生体から放出される光強度を検出する光強度検出ステップ、
前記光強度検出ステップにより検出された前記光強度に基づき前記生体内における光の散乱係数を算出する散乱係数算出ステップ、及び
前記算出された散乱係数に基づき脂質濃度を算出する脂質濃度算出ステップ、を有し、
前記散乱係数算出ステップは、前記光強度検出ステップにより検出された前記光強度が、前記生体内の血中を透過しているか否かを判別するステップを含み、該ステップにより前記生体内の血中を透過したと判別された光の散乱係数を算出する、
非侵襲型生体脂質を計測する方法。 A method for measuring lipids in blood in a living body,
An irradiation step of irradiating light at a predetermined light intensity from outside the living body toward the living body;
A light intensity detection step of detecting light intensity emitted from the living body through scattering in the living body of the irradiation light in the irradiation step;
A scattering coefficient calculating step for calculating a light scattering coefficient in the living body based on the light intensity detected by the light intensity detecting step; and a lipid concentration calculating step for calculating a lipid concentration based on the calculated scattering coefficient. Have
The scattering coefficient calculating step includes a step of determining whether or not the light intensity detected by the light intensity detecting step is transmitted through the blood in the living body, and the blood in the living body is determined by the step. Calculating the scattering coefficient of the light determined to have passed through,
A method for measuring non-invasive biological lipids.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2016/050560 WO2017119130A1 (en) | 2016-01-08 | 2016-01-08 | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method |
| JP2017560017A JP6604611B2 (en) | 2016-01-08 | 2016-01-08 | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2016/050560 WO2017119130A1 (en) | 2016-01-08 | 2016-01-08 | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2017119130A1 true WO2017119130A1 (en) | 2017-07-13 |
Family
ID=59273420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2016/050560 Ceased WO2017119130A1 (en) | 2016-01-08 | 2016-01-08 | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP6604611B2 (en) |
| WO (1) | WO2017119130A1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3505044A1 (en) * | 2017-12-29 | 2019-07-03 | Samsung Electronics Co., Ltd. | Biological component measuring apparatus and biological component measuring method |
| WO2019208718A1 (en) * | 2018-04-26 | 2019-10-31 | メディカルフォトニクス株式会社 | Lipid concentration measurement device and method therefor |
| JP2019201760A (en) * | 2018-05-22 | 2019-11-28 | メディカルフォトニクス株式会社 | Blood vessel detection device and method thereof |
| JP2020003411A (en) * | 2018-06-29 | 2020-01-09 | メディカルフォトニクス株式会社 | Device and method for measuring lipid |
| WO2020080409A1 (en) * | 2018-10-17 | 2020-04-23 | メディカルフォトニクス株式会社 | Particle concentration measurement device, particle concentration measurement program, and particle concentration measurement method |
| WO2020246455A1 (en) * | 2019-06-04 | 2020-12-10 | メディカルフォトニクス株式会社 | Non-invasive measuring device, method, and program |
| WO2022220209A1 (en) * | 2021-04-13 | 2022-10-20 | メディカルフォトニクス株式会社 | Lipid concentration measuring device, program, and method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07148170A (en) * | 1993-11-30 | 1995-06-13 | Technol Res Assoc Of Medical & Welfare Apparatus | Optical biological measuring apparatus |
| JPH0889500A (en) * | 1993-12-16 | 1996-04-09 | Iss Usa Inc | Optical sensor with multiple light sources |
| JPH10258036A (en) * | 1997-03-19 | 1998-09-29 | Matsushita Electric Ind Co Ltd | Blood glucose meter |
| JP2000507348A (en) * | 1996-03-19 | 2000-06-13 | ユニヴァーシティ カレッジ ロンドン | Measurement of extinction coefficient and modified scattering coefficient |
| JP2012110520A (en) * | 2010-11-25 | 2012-06-14 | Nippon Koden Corp | Sensor mounting time period-informing method and apparatus |
-
2016
- 2016-01-08 WO PCT/JP2016/050560 patent/WO2017119130A1/en not_active Ceased
- 2016-01-08 JP JP2017560017A patent/JP6604611B2/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07148170A (en) * | 1993-11-30 | 1995-06-13 | Technol Res Assoc Of Medical & Welfare Apparatus | Optical biological measuring apparatus |
| JPH0889500A (en) * | 1993-12-16 | 1996-04-09 | Iss Usa Inc | Optical sensor with multiple light sources |
| JP2000507348A (en) * | 1996-03-19 | 2000-06-13 | ユニヴァーシティ カレッジ ロンドン | Measurement of extinction coefficient and modified scattering coefficient |
| JPH10258036A (en) * | 1997-03-19 | 1998-09-29 | Matsushita Electric Ind Co Ltd | Blood glucose meter |
| JP2012110520A (en) * | 2010-11-25 | 2012-06-14 | Nippon Koden Corp | Sensor mounting time period-informing method and apparatus |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11013412B2 (en) | 2017-12-29 | 2021-05-25 | Samsung Electronics Co., Ltd. | Biological component measuring apparatus and biological component measuring method |
| US11607133B2 (en) | 2017-12-29 | 2023-03-21 | Samsung Electronics Co., Ltd. | Biological component measuring apparatus and biological component measuring method |
| EP3505044A1 (en) * | 2017-12-29 | 2019-07-03 | Samsung Electronics Co., Ltd. | Biological component measuring apparatus and biological component measuring method |
| JPWO2019208718A1 (en) * | 2018-04-26 | 2021-05-27 | メディカルフォトニクス株式会社 | Lipid concentration measuring device and its method |
| CN112040867A (en) * | 2018-04-26 | 2020-12-04 | 医疗光电设备有限公司 | Lipid concentration measuring apparatus and method therefor |
| WO2019208718A1 (en) * | 2018-04-26 | 2019-10-31 | メディカルフォトニクス株式会社 | Lipid concentration measurement device and method therefor |
| WO2019225612A1 (en) * | 2018-05-22 | 2019-11-28 | メディカルフォトニクス株式会社 | Blood vessel detection device and method therefor |
| JP2019201760A (en) * | 2018-05-22 | 2019-11-28 | メディカルフォトニクス株式会社 | Blood vessel detection device and method thereof |
| JP7093963B2 (en) | 2018-05-22 | 2022-07-01 | メディカルフォトニクス株式会社 | Blood vessel detector |
| JP2020003411A (en) * | 2018-06-29 | 2020-01-09 | メディカルフォトニクス株式会社 | Device and method for measuring lipid |
| WO2020080409A1 (en) * | 2018-10-17 | 2020-04-23 | メディカルフォトニクス株式会社 | Particle concentration measurement device, particle concentration measurement program, and particle concentration measurement method |
| WO2020246455A1 (en) * | 2019-06-04 | 2020-12-10 | メディカルフォトニクス株式会社 | Non-invasive measuring device, method, and program |
| WO2022220209A1 (en) * | 2021-04-13 | 2022-10-20 | メディカルフォトニクス株式会社 | Lipid concentration measuring device, program, and method |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6604611B2 (en) | 2019-11-13 |
| JPWO2017119130A1 (en) | 2018-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6604611B2 (en) | Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method | |
| JP5684443B2 (en) | Biological component measuring device | |
| JP6120647B2 (en) | Subject information acquisition apparatus and control method thereof | |
| US8426819B2 (en) | Method for the non-invasive optic determination of the temperature of a medium | |
| JP4643273B2 (en) | Apparatus for blood measurement | |
| RU2727242C2 (en) | Method and device for non-invasive optical in vivo determination of glucose concentration in leaking blood | |
| US10265544B2 (en) | Real-time tumor perfusion imaging during radiation therapy delivery | |
| EP3797687A1 (en) | Blood vessel detection device and method therefor | |
| JP2021014988A (en) | Measurement device | |
| US9566006B2 (en) | Object information acquisition apparatus | |
| JP5964773B2 (en) | Temperature measuring method and apparatus | |
| WO2018151150A1 (en) | Device and method for measuring scattered body concentration | |
| JP7029788B2 (en) | Flow measuring device, flow measuring method and flow measuring program | |
| US20200359938A1 (en) | Lipid measurement device and method therefor | |
| KR101961147B1 (en) | Apparatus for measurements non-invasive blood sugar, method for measurements non-invasive blood glucose using the apparatus | |
| US12471779B2 (en) | Blood vessel detection device and method therefor | |
| US20200245929A1 (en) | Lipid measuring apparatus and lipid measuring method | |
| RU2517155C1 (en) | Method for determining haemoglobin derivative concentrations in biological tissues | |
| EP3982112A1 (en) | Non-invasive measuring device, method, and program | |
| KR20240084181A (en) | Skin Condition Monitoring Apparatus Using Laser Optical Module | |
| JP6850257B2 (en) | Non-invasive method for measuring physiological parameters via confocal spectroscopy | |
| Lisenko et al. | Determination of constituent composition of hemoglobin and structural/morphological parameters of skin based on approximating functions for radiation fluxes backscattered from skin | |
| US20210059575A1 (en) | Lipid concentration measurement device and method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16883633 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2017560017 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 16883633 Country of ref document: EP Kind code of ref document: A1 |